As the United States stock market navigates uncertainties such as potential government shutdowns and fluctuating commodity prices, major indices like the Dow Jones, Nasdaq, and S&P 500 have shown resilience with recent gains. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer value beyond current market perceptions.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Trade Desk (TTD) |
$49.64 |
$96.49 |
48.6% |
|
Phibro Animal Health (PAHC) |
$39.15 |
$77.67 |
49.6% |
|
Northwest Bancshares (NWBI) |
$12.43 |
$24.41 |
49.1% |
|
NeuroPace (NPCE) |
$10.24 |
$20.04 |
48.9% |
|
Metropolitan Bank Holding (MCB) |
$75.44 |
$150.26 |
49.8% |
|
Investar Holding (ISTR) |
$23.13 |
$44.89 |
48.5% |
|
Horizon Bancorp (HBNC) |
$16.13 |
$31.76 |
49.2% |
|
Glaukos (GKOS) |
$81.28 |
$161.55 |
49.7% |
|
Customers Bancorp (CUBI) |
$65.60 |
$131.16 |
50% |
|
AbbVie (ABBV) |
$223.16 |
$438.05 |
49.1% |
Let's dive into some prime choices out of the screener.
Overview: Phibro Animal Health Corporation is an animal health and mineral nutrition company with operations across the United States, Latin America and Canada, Europe, the Middle East, Africa and the Asia Pacific, with a market cap of approximately $1.57 billion.
Operations: Phibro Animal Health's revenue is primarily derived from its Animal Health segment at $962.80 million, followed by Mineral Nutrition at $253.24 million and Performance Products at $80.18 million.
Estimated Discount To Fair Value: 49.6%
Phibro Animal Health appears undervalued, trading at $39.15, significantly below its estimated fair value of $77.67. Despite revenue growth forecasts of 5.6% annually—below the US market average—earnings are expected to grow robustly at 26.6% per year, outpacing the market's 15.4%. Recent earnings reports show a substantial increase in net income and EPS compared to last year, indicating strong cash flow potential despite debt coverage concerns by operating cash flow.
Overview: Northwest Bancshares, Inc. is the bank holding company for Northwest Bank, offering personal and business banking solutions in the United States, with a market cap of approximately $1.83 billion.
Operations: The company generates revenue of $561.86 million from its banking segment, providing a range of financial services in the United States.

